Complete Erectile Dysfunction Treatment Guide

An in-depth clinical guide covering causes of erectile dysfunction,
pharmacological treatment options, combination therapy strategies,
and evidence-based approaches for restoring erectile performance.

Understanding Erectile Dysfunction

Erectile dysfunction (ED) refers to the persistent inability to achieve
or maintain an erection sufficient for satisfactory sexual performance.
Although the condition becomes more common with age,
it is not exclusively an age-related disorder.
Many men experience ED due to metabolic, cardiovascular,
neurological, or psychological factors.

Modern research increasingly recognizes erectile dysfunction
as an early marker of vascular disease.
Because penile arteries are smaller than coronary arteries,
vascular impairment may appear in erectile function years before
cardiovascular symptoms develop.

For this reason, ED is often considered not only a quality-of-life condition
but also a potential indicator of broader cardiovascular health.

Common Causes of Erectile Dysfunction

Vascular Dysfunction

The most common physiological cause of ED involves impaired blood flow.
Healthy erections require efficient arterial inflow and controlled venous outflow.
Conditions that affect vascular health can therefore reduce erectile rigidity.

• Atherosclerosis
• Hypertension
• Diabetes mellitus
• Smoking-related endothelial damage
• Obesity and metabolic syndrome

Because penile arteries are relatively small,
even mild vascular narrowing may significantly reduce blood flow.

Neurological Factors

Erection is a neurovascular process requiring proper signaling
between the brain, spinal cord, and penile nerves.
Neurological disruption may impair erectile function.

Examples include:

• Spinal cord injury
• Peripheral neuropathy
• Multiple sclerosis
• Pelvic nerve damage after surgery

Hormonal Factors

Testosterone plays an important role in libido and erectile function.
While most ED cases are not caused solely by hormonal deficiency,
low testosterone levels can contribute to reduced sexual desire
and diminished erectile response.

Psychological Contributors

Mental health factors can also influence erectile performance.
Performance anxiety, chronic stress, depression,
and relationship dynamics may disrupt the neural pathways
necessary for erection initiation.

First-Line Treatment: PDE-5 Inhibitors

Phosphodiesterase-5 inhibitors remain the primary pharmacological treatment
for erectile dysfunction.
These medications enhance nitric oxide signaling,
allowing increased blood flow to penile tissue during sexual stimulation.

Most patients respond well to these medications when dosing,
timing, and sexual stimulation are optimized.

When Combination Therapy Is Considered

Combination therapy may be explored when monotherapy fails
to produce sufficient erectile rigidity or arousal.

Common escalation approaches include:

• PDE-5 inhibitor + Apomorphine
• PDE-5 inhibitor + Dapoxetine (ED with premature ejaculation)
• Structured neurovascular combination therapy

However, combining multiple PDE-5 inhibitors simultaneously
is generally considered an advanced escalation strategy
and should be approached cautiously.

Safety Considerations

Although PDE-5 inhibitors are generally well tolerated,
they are contraindicated in specific medical situations.

• Concurrent nitrate therapy
• Severe hypotension
• Recent myocardial infarction or stroke
• Unstable cardiovascular disease

Patients with complex medical histories should consult a qualified clinician
before initiating combination therapy.

Evidence-Based Treatment Strategy

Clinical treatment typically follows a stepwise approach:

Step 1: Optimize single-agent PDE-5 dosing
Step 2: Evaluate response and side effects
Step 3: Consider targeted combination therapy
Step 4: Investigate underlying causes if treatment fails

This structured escalation ensures treatment remains both effective
and medically responsible.

Educational information only. Consult a healthcare professional before initiating therapy.